Navigation Links
Life Sciences Entrepreneurs S.L.U. Announces the First Financing of the Antiplatelet Candidate NmC by Spanish and Swiss Investors
Date:11/5/2012

BARCELONA, Spain, November 5, 2012 /PRNewswire/ --

Life Science Entrepreneurs S.L.U., a company dedicated to the early-stage development of high-risk/very high return ventures, announced today the conclusion of a first investment for an antiplatelet drug candidate code-named NmC.

Private investors from Barcelona, Geneva and Basel, all active in medical applications of life sciences, have funded the assays to confirm the safety and efficacy of the cardiovascular drug NmC.

"NmC might prevent cardiovascular incidents thanks to the unique way it dilutes the blood of at-risk patients", said François Arcand, President of Life Science Entrepreneurs S.L.U. "The drug candidate catches the interest of experts in the field because its novel mechanism of action could set it apart from antiplatelets like the standard-of-care Plavix® or the newcomer Eliquis®".

The molecule has been licensed from a foreign university. In early 2013, Life Science Entrepreneurs S.L.U. will raise two million euro to conduct a complete set of regulatory pre-clinical assays from Spanish and foreign investors.

About …

Life Science Entrepreneurs S.L. develops scientific discoveries up to the completion of a viable proof-of-concept, when successful technologies are susceptible to be acquired by well-funded specialized organizations.  For more, see http://www.LifSciE.com

Français : http://www.lifscie.com/fr/enemce/

Español: http://www.lifscie.com/es/enemce/

Català : http://www.lifscie.com/cat/en/enemce/


'/>"/>
SOURCE Life Science Entrepreneurs S.L.U.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Advantages of Pressure BioSciences PCT Platform Highlighted at a Recent International Scientific Conference Focused on the Role of Proteins in the Cause, Prevention, and Treatment of Disease
2. Parios Regenerative Sciences, Inc. Licenses Exclusive Rights to Organic Nanotechnology for Skin Repair
3. Keynote Presentation at Upcoming International Microbiology & Genomics Meeting to Highlight Ability of Pressure BioSciences Patented PCT Platform to Improve Testing for Biological Threat Organisms, Human Infectious Diseases, and Contaminated Food P
4. Amarantus BioSciences Announces MANF Demonstrates Superiority over GDNF in Neurorestoration Behavioural Animal Model of Parkinsons Disease
5. Call for Submissions: ICAP Patent Brokerage Announces Expansion of Life Sciences Practice and Increased Buyer Interest in Related Intellectual Property
6. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2012 Financial Results
7. Trovagene and Strand Life Sciences Agree to Validate and Commercialize Urine-Based HPV Test in India and South Asia
8. Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference
9. Rigel to Present at UBS Global Life Sciences Conference
10. HeartWare Presentation at the UBS Global Life Sciences Conference to be Webcast
11. Avanir Pharmaceuticals To Present At UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... 2016 One of Australia,s successful ... of a new biotechnology company, Noxopharm Limited [ABN 50 608 966 ... and to list on the ASX. Noxopharm is a ... enter a Phase 1 clinical study later this year. ... of the biggest problems facing cancer patients - the ability of ...
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many ... the beholder, according to experts who offered insights and commentary in the current issue ... the full issue, click here . , For the American Society of Clinical ...
(Date:6/26/2016)... Michigan (PRWEB) , ... June 26, 2016 , ... ... to fertility once they have been diagnosed with endometriosis. These women need a ... they also require a comprehensive approach that can help for preservation of fertility ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
Breaking Medicine News(10 mins):